Step 8: Establish your screening baseline

steps This section covers the following steps:

Step 8.1 Establish your bowel cancer screening baseline
Step 8.2 Establish your breast cancer screening baseline
Step 8.3 Establish your cervical cancer screening baseline

Congratulations, now that you have completed steps 1-7 you have significantly improved the accuracy of your cancer screening data.

It is important to establish your basedline participation rates for the bowel, breast and cervical screening programs.This will allow you to:

  • benchmark your performance against state averages
  • compare your actual performance against your perceived performance (practices often find that screening participation in their practice is lower than anticipated)
  • track your improvement over time as a result of your cancer screening quality improvement activities

Here, you will be guided through extracting your screening participation baseline data.

Before you begin, it is important to decide:

  • where you will record your participation rates (a clearly labelled excel or word document is a simple solution)
  • how often you will monitor your participation rates (quarterly is recommended, as this allows some time to see change)
  • how and ‘how often’ you will share and celebrate progress with the practice team (team newsletters, lunch room display, team meetings, etc).

Step 8.1 Establish your bowel cancer screening baseline

Goal 60% per cent: The percentage of men and women aged 50–74 who have completed a bowel screening test (iFOBT) in the previous 2 years.
Measure

Numerator: The number of active patients, aged 50–74 years, who have completed an iFOBT in the previous 2 years.

Denominator: The number of active patients aged 50–74 years eligible for the National Bowel Cancer Screening Program.

 

Extracting bowel cancer screening baseline data

Step 8.2 Establish your breast cancer screening baseline

Goal 70%: The percentage of women aged between 50–74 years with a recorded result for a mammogram conducted in the previous 2 years.
Measure

Numerator: The number of active female patients, aged 50–74 years, who have had a bilateral breast screen mammogram within the previous two years.

Denominator: The number of active female patients aged 50–74 years eligible for a screening mammogram.

Extracting breast cancer screening baseline data

As per the information outlined in Step 5, if you are undertaking prospective clean-up of your BreastScreen NSW data:

  • your BreastScreen NSW participation rate will become more accurate over time
  • changes to your participation rate will reflect both improvements in data and increases in participation resulting from cancer screening quality improvement activities.
     
  • Breast cancer screening participation rate

Step 8.3 Establish your cervical cancer screening baseline

Goal 65%: The percentage of women aged between 25–74 years with a recorded result for a cervical screening test conducted in the recommended timeframe.
Measure

Numerator: The number of active female patients aged between 25–74 years who have had a Pap test in the previous 2 years OR a Cervical Screening Test in the previous 5 years.

Denominator: The number of active female patients aged between 25–74 years who are eligible for the National Cervical Screening Program.